Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14451 - 14475 of 14794 in total
Setrobuvir has been used in trials studying the treatment of Hepatitis C, Chronic.
Investigational
Matched Description: … Setrobuvir has been used in trials studying the treatment of Hepatitis C, Chronic. …
Oxycyte has been used in trials studying the treatment of Traumatic Brain Injury.
Investigational
Matched Description: … Oxycyte has been used in trials studying the treatment of Traumatic Brain Injury. …
Tedatioxetine has been used in trials studying the treatment of Major Depressive Disorder.
Investigational
Matched Description: … Tedatioxetine has been used in trials studying the treatment of Major Depressive Disorder. …
GSI-136 has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Description: … GSI-136 has been used in trials studying the treatment of Alzheimer Disease. …
AZD7325 is a high affinity, selective modulator of the GABAA receptor system.
Investigational
Matched Description: … AZD7325 is a high affinity, selective modulator of the GABAA receptor system. [L2936] …
TNG908 is a small molecule inhibitor of protein arginine methyl transferase 5 (PRMT5).
Investigational
Matched Description: … TNG908 is a small molecule inhibitor of protein arginine methyl transferase 5 (PRMT5). …
BMS-488043 has been investigated as an anti-HIV agent.
Investigational
R1204 is G-protein-coupled receptor modulator. It is developed for the treatment of depression.
Investigational
Matched Description: … It is developed for the treatment of depression. …
Petesicatib is under investigation in clinical trial NCT02295332 (A Study of RG7625 in Healthy Volunteers).
Investigational
Matched Description: … Petesicatib is under investigation in clinical trial NCT02295332 (A Study of RG7625 in Healthy Volunteers …
KW-6356 is a selective antagonist of adenosine A2A receptors developed by Kyowa Kirin.
Experimental
Matched Description: … KW-6356 is a selective antagonist of adenosine A2A receptors developed by Kyowa Kirin.[L43822] …
KT-253 is a selective heterobifunctional small molecule degrader of mouse double minute 2 (MDM2).
Investigational
Matched Description: … KT-253 is a selective heterobifunctional small molecule degrader of mouse double minute 2 (MDM2). …
Malonaldehyde is the dialdehyde of malonic acid.
Experimental
Matched Description: … Malonaldehyde is the dialdehyde of [malonic acid]. …
Zingerone is a pungent component of ginger.
Experimental
Matched Description: … Zingerone is a pungent component of ginger. …
CG0070 is investigated in clinical trials for treating bladder cancer. CG0070 is a solid. CG0070 can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and immune-mediated cell killing stimulated by GM-CSF. CG0070, an oncolytic virus therapy with specificity for multiple cancers, has been evaluated...
Investigational
Matched Description: … can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and
Safingol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Description: … Safingol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific …
Butylamine is a colourless liquid which acquires a yellow colour upon storage in air. It is one of the four isomeric amines of butane. It is known to have the fishy, ammonia-like odor common to amines.
Experimental
Matched Description: … It is one of the four isomeric amines of butane. …
Displaying drugs 14451 - 14475 of 14794 in total